KDIGO (CKD-MBD) Update

This activity will highlight the key aspects of the 2017 CKD-MBD Guideline Update, with an emphasis on the rationale for the changes made to the original guideline document. Topics that will be addressed include diagnosis of bone abnormalities in CKD mineral and bone disorder, treatment of CKD-MBD by targeting phosphate lowering and calcium maintenance, treatment of abnormalities in parathyroid hormone in CKD-MBD, treatment of bone abnormalities by antiresorptives and other osteoporosis therapies, and evaluation and treatment of kidney transplant bone disease.

    Target Audience

    • Dietitians
    Method of Participation:

    Learners will review the materials on accreditation information, target audience, learning objectives, and disclosure information; complete the pre-test; review the video content; complete the post-test (minimum score of 70% required; learners will only have 3 attempts to pass the post-test) and evaluation to successfully earn credit.

    If you participated in the live symposium KDIGO (CKD-MBD) Update on April 12, 2018 and claimed credit, you should not claim credit for this endured activity.

    Learning Objectives

    After participation in this activity, learners will be better able to:

    • Describe the grading system used to determine the strength of the guidelines and evaluate the updates related to calcium, phosphorus and PTHi levels in both the adult and pediatric populations
    • Differentiate sources of phosphorus in the diet (organic, inorganic, addition to food supply) and describe patient recommendations RDs can make to better achieve adequate phosphorus control
    • Estimate how dialysis providers and government oversite will use these guidelines to adjust expected outcomes for the stages of CKD

    You may also be interested in

    Food First: Treating CKD with Diet

    Dietary interventions have been shown to benefit several CKD complications and unfortunately are underused.  We argue that diet should be the first CKD interventions with pharmacotherapy being adjunctive.
    Cardiovascular Risk in Patients with Chronic Kidney Disease (CKD) The Impact of Anemia

    This activity addresses the clinical challenge of treating anemia in CKD. Content focuses on CKD-related anemia and cardiovascular risk. The program also reviews benefits and limitations of current treatment options and explore emerging strategies for treating anemia in CKD.
    Course summary
    Available credit: 
    • 1.50 Attendance
    • 1.50 CDR CPEUs
    Course opens: 
    01/28/2019
    Course expires: 
    01/28/2021
    Cost:
    $35.00
    Rating: 
    0
    Faculty Disclosures:

    Linda McCann, RD, CSR
    Nephrology Nutrition Consultant/Speaker
    Eagle, ID
    Disclosure: Consulting: Sanofi; Honoraria: Amgen

    Planning Committee Disclosures:

    Mary Sundell, MLAS, RD, LDN, FNKF
    Dietitian II, Multi Specialties TVC
    Vanderbilt
    Nashville, TN
    Disclosure: Has no financial relationships with commercial interest(s).

    Beth Shanaman, RD
    Registered Dietitian
    Northwest Kidney Centers
    Seattle, WA
    Disclosure: Has no financial relationships with commercial interest(s).

    Danielle Nathan, MA
    Senior Director, Professional Education 
    National Kidney Foundation
    New York, NY
    Disclosure: Has no financial relationships with commercial interest(s).

    Kathryn Troy, MPH
    Professional Education Manager
    National Kidney Foundation
    New York, NY
    Disclosure: Has no financial relationships with commercial interest(s).

    Declaration of Disclosure:

    It is the policy of the National Kidney Foundation (NKF) to ensure balance, independence, objectivity, and scientific rigor in all CME/CE activities. Any individual who has control over CME/CE content is required to disclose to learners prior to the activity any relevant financial relationship(s) they may have with commercial interests supporting this activity or whose products or devices are discussed in this activity.  

    If, on the basis of information disclosed, a perceived conflict exists, resolution will be achieved based on NKF's Disclosure and Conflict of Interest Policy.

    Unlabeled/Investigational Use:

    During their presentations, faculty may discuss an unlabeled use or an investigational use not approved for a commercial product. Each faculty member is required to disclose this information to the audience when referring to an unlabeled or investigational use.

    Dietitian

    The National Kidney Foundation is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). CDR Credentialed Practitioners will receive 1.5 Continuing Professional Education Units (CPEUs) for completion of this activity/material.

    Available Credit

    • 1.50 Attendance
    • 1.50 CDR CPEUs

    Accreditation Period

    Course opens: 
    01/28/2019
    Course expires: 
    01/28/2021

    Price

    Cost:
    $35.00
    Please login or register for a PERC account to take this course.
    Disclaimer:

    The faculty and National Kidney Foundation (NKF) do not recommend the use of any pharmaceutical, diagnostic test, or device outside of the labeled indications as approved by the FDA. Please refer to the official prescribing information for each product for approved indications, contraindications, and warnings.

    Information contained in this NKF educational resource is based upon current data available at the time of publication. Information is intended to help clinicians become aware of new scientific findings and developments.  This NKF educational resource is not intended to set out a preferred standard of care and should not be construed as one. Neither should the information be interpreted as prescribing an exclusive course of management.

    Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every healthcare professional making use of information in this NKF educational resource is responsible for interpreting the data as it pertains to clinical decision making in each individual patient.

    Required Hardware/software

    System requirements can be found here.

    Contact Information:

    For any questions concerning this activity, please send an email to CMEinfo@kidney.org or call NKF at 1-800-622-9010.

    To view NKF privacy and confidentiality policy as it relates to CME/CE activity, please visit http://www.kidney.org/

    For additional professional education resources, contact NKF at 1-800-622-9010 or visit https://www.kidney.org/professionals